In situ localization of interferons in psoriatic lesions
- PMID: 2480752
- DOI: 10.1007/BF00455323
In situ localization of interferons in psoriatic lesions
Abstract
An indirect immunofluorescence technique, using murine monoclonal antibodies (MoAbs) against human IFN-alpha and human IFN-gamma was used to study IFNs in cryostat sections from psoriatic skin lesions. The IFNs were more pronounced in sections from highly active psoriasis than in sections from stationary psoriasis. In highly active psoriatic lesions IFN-alpha was localized to keratinocytes is stratum basale, to some epidermal dendritic cells, probably Langerhans cells, and to some mononuclear cells in dermis. IFN-alpha was usually not detected in sections from stationary psoriasis. IFN-gamma was localized to stratum corneum, to keratinocytes around microabcesses and to mononuclear cells in the dermal cell infiltrates, predominantly in highly active psoriatic lesions. Both IFN-alpha and IFN-gamma were localized to some endothelial cells in the papillary dermis. The MoAbs did not stain sections from unaffected skin from patients with psoriasis or sections from healthy individuals. The findings indicate that the IFN system in the skin may be of significance in the pathophysiology of psoriasis.
Similar articles
-
Type1 Interferons Potential Initiating Factors Linking Skin Wounds With Psoriasis Pathogenesis.Front Immunol. 2019 Jun 25;10:1440. doi: 10.3389/fimmu.2019.01440. eCollection 2019. Front Immunol. 2019. PMID: 31293591 Free PMC article. Review.
-
Immunohistopathologic studies in the development of psoriatic lesion influenced by gamma-interferon and the producing cells.J Dermatol Sci. 1990 Nov;1(6):425-34. doi: 10.1016/0923-1811(90)90012-3. J Dermatol Sci. 1990. PMID: 2126953
-
In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.J Immunol. 2006 Feb 1;176(3):1908-15. doi: 10.4049/jimmunol.176.3.1908. J Immunol. 2006. PMID: 16424222
-
Expression of interferon-gamma receptors in normal and psoriatic skin.J Invest Dermatol. 1992 Feb;98(2):255-8. doi: 10.1111/1523-1747.ep12556086. J Invest Dermatol. 1992. PMID: 1531061
-
Immune functions and recruitment of plasmacytoid dendritic cells in psoriasis.Autoimmunity. 2010 Apr;43(3):215-9. doi: 10.3109/08916930903510906. Autoimmunity. 2010. PMID: 20166874 Review.
Cited by
-
DNA Damage and Deficiencies in the Mechanisms of Its Repair: Implications in the Pathogenesis of Systemic Lupus Erythematosus.J Immunol Res. 2018 Jul 12;2018:8214379. doi: 10.1155/2018/8214379. eCollection 2018. J Immunol Res. 2018. PMID: 30116756 Free PMC article. Review.
-
Type1 Interferons Potential Initiating Factors Linking Skin Wounds With Psoriasis Pathogenesis.Front Immunol. 2019 Jun 25;10:1440. doi: 10.3389/fimmu.2019.01440. eCollection 2019. Front Immunol. 2019. PMID: 31293591 Free PMC article. Review.
-
Macrophage Response to Simulated Solar Radiation in the Development of Human Malignant Melanoma.Arch Clin Exp Dermatol. 2021 Apr;3(1):119. doi: 10.46527/2583-6374.119. Epub 2021 Apr 30. Arch Clin Exp Dermatol. 2021. PMID: 37309359 Free PMC article.
-
Reappraisal of in situ immunophenotypic analysis of psoriasis skin: interaction of activated HLA-DR+ immunocompetent cells and endothelial cells is a major feature of psoriatic lesions.Arch Dermatol Res. 1994;286(2):87-96. doi: 10.1007/BF00370733. Arch Dermatol Res. 1994. PMID: 7512323
-
Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus.J Virol. 2005 Apr;79(8):4838-47. doi: 10.1128/JVI.79.8.4838-4847.2005. J Virol. 2005. PMID: 15795269 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical